基于结构优化,设计,合成和研究氏纤维酸-瓦尼林衍生物的降脂和肝脏保护作用,基于结构优化
Yumiao Song1, Xinyi Shi1, Xinyu Zhang1
1College of Pharmacy, Shaanxi University of Chinese Medicine, Shiji Ave., Xi'an-xianyang New Ecomic Zone, Shaanxi Province 712046, People's Republic of China.
Bioorganic & medicinal chemistry letters
|June 14, 2025
概括
一种新型化合物 - - 克洛菲布拉特 - - 瓦尼林 (CF-Vanillin) 有效地降低了小鼠的甘油三和胆固醇. 这种新药还显著减少了肝损伤,提供了一个有前途的治疗选择.
科学领域:
- 药理学 药理学是指药理学的学科.
- 肝病学 肝病学是一种肝病学.
- 药用化学 医学化学
背景情况:
- 克洛菲布拉特是一种降脂剂,可导致肝损伤.
- 优化克洛菲布拉特的结构对于开发更安全的替代品至关重要.
研究的目的:
- 合成和评估纤维瓦尼林 (CF-Vanillin) 作为一种降脂药物,降低肝毒性.
- 为了研究CF-瓦尼林的作用背后的分子机制.
主要方法:
- 合成CF-瓦尼林并给高脂血症小鼠使用.
- 评估脂质特征 (甘油三,总胆固醇) 和肝功能标志物 (AST,ALT).
- 分子对接研究,肝脏组织病理学和Nrf2/HO-1通路激活的分析.
主要成果:
- 与克洛菲布拉特相比,CF-瓦尼林显示出更好的降脂效果.
- CF-瓦尼林显著降低了肝损伤标志物,肝脏重量和肝脏系数.
- 组织病理学分析显示肝细胞死亡和炎症的减少.
- CF-瓦尼林上调了Nrf2和HO-1的表达,表明抗氧化和抗炎活性.
结论:
- CF-瓦尼林是一种强大的降脂剂,具有显著降低的肝损伤特性.
- 它的治疗效益可能通过激活Nrf2/HO-1信号通路来调解.
- CF-瓦尼林代表了治疗高脂血症的有前途的候选人,具有改善的安全性.
更多相关视频
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
601
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
601
Structure-Activity Relationships and Drug Design
684
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
684
Drug Discovery: Overview
7.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K
Drug Biotransformation: Overview
2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K


